Vir Grows with $500M in Financing, Humabs Acquisition, Two Up-to-$1B Collaborations
Less than a year after its launch, Vir Biotechnology today disclosed it has secured more than $500 million in financing toward an acquisition and a series of collaborations launched with two companies—each of which could generate over $1 billion—and four top-tier academic research institutions.The collaborations, acquisition, and financing are aimed at building the company’s pipeline, technology, and global footprint, all with the goal of developing treatments for infectious di
Read more »